These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30815900)

  • 1. Allogeneic hematopoietic cell transplantation in Farber disease.
    Ehlert K; Levade T; Di Rocco M; Lanino E; Albert MH; Führer M; Jarisch A; Güngör T; Ayuk F; Vormoor J
    J Inherit Metab Dis; 2019 Mar; 42(2):286-294. PubMed ID: 30815900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analyses of novel ASAH1 mutations causing Farber lipogranulomatosis: analyses of exonic splicing enhancer inactivating mutation.
    Bashyam MD; Chaudhary AK; Kiran M; Reddy V; Nagarajaram HA; Dalal A; Bashyam L; Suri D; Gupta A; Gupta N; Kabra M; Puri RD; RamaDevi R; Kapoor S; Danda S
    Clin Genet; 2014 Dec; 86(6):530-8. PubMed ID: 24355074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy.
    Elsea SH; Solyom A; Martin K; Harmatz P; Mitchell J; Lampe C; Grant C; Selim L; Mungan NO; Guelbert N; Magnusson B; Sundberg E; Puri R; Kapoor S; Arslan N; DiRocco M; Zaki M; Ozen S; Mahmoud IG; Ehlert K; Hahn A; Gokcay G; Torcoletti M; Ferreira CR
    Hum Mutat; 2020 Sep; 41(9):1469-1487. PubMed ID: 32449975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of acid ceramidase deficiency in a neonatal form of Farber disease: identification of the first large deletion in ASAH1 gene.
    Alves MQ; Le Trionnaire E; Ribeiro I; Carpentier S; Harzer K; Levade T; Ribeiro MG
    Mol Genet Metab; 2013 Jul; 109(3):276-81. PubMed ID: 23707712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis.
    Zhang H; Nagree MS; Liu H; Pan X; Medin JA; Lipinski DM
    Gene Ther; 2023 Apr; 30(3-4):297-308. PubMed ID: 35902747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farber disease in a patient from China.
    Bao X; Ma M; Zhang Z; Xu Y; Qiu Z
    Am J Med Genet A; 2020 Sep; 182(9):2184-2186. PubMed ID: 32706452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel V97G ASAH1 mutation found in Farber disease patients: unique appearance of the disease with an intermediate severity, and marked early involvement of central and peripheral nervous system.
    Chedrawi AK; Al-Hassnan ZN; Al-Muhaizea M; Colak D; Al-Younes B; Albakheet A; Tulba S; Kaya N
    Brain Dev; 2012 May; 34(5):400-4. PubMed ID: 21893389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farber lipogranulomatosis type 1--late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation.
    Cvitanovic-Sojat L; Gjergja Juraski R; Sabourdy F; Fensom AH; Fumic K; Paschke E; Levade T
    Eur J Paediatr Neurol; 2011 Mar; 15(2):171-3. PubMed ID: 20609603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical presentation of infantile-onset farber disease with novel ASAH1 mutations.
    Kim SY; Choi SA; Lee S; Lee JS; Hong CR; Lim BC; Kang HJ; Kim KJ; Park SH; Choi M; Chae JH
    Am J Med Genet A; 2016 Nov; 170(11):3023-3027. PubMed ID: 27411168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease.
    Ramsubir S; Nonaka T; Girbés CB; Carpentier S; Levade T; Medin JA
    Mol Genet Metab; 2008 Nov; 95(3):133-41. PubMed ID: 18805722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment.
    Yu FPS; Sajdak BS; Sikora J; Salmon AE; Nagree MS; Gurka J; Kassem IS; Lipinski DM; Carroll J; Medin JA
    Am J Pathol; 2019 Feb; 189(2):320-338. PubMed ID: 30472209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy.
    Gan JJ; Garcia V; Tian J; Tagliati M; Parisi JE; Chung JM; Lewis R; Baloh R; Levade T; Pierson TM
    Neuromuscul Disord; 2015 Dec; 25(12):959-63. PubMed ID: 26526000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal muscular atrophy and Farber disease due to ASAH1 variants: A case report.
    Lee BH; Mongiovi P; Levade T; Marston B; Mountain J; Ciafaloni E
    Am J Med Genet A; 2020 Oct; 182(10):2369-2371. PubMed ID: 32627310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Odontoid infiltration and spinal compression in Farber Disease: reversal by haematopoietic stem cell transplantation.
    Jarisch A; Steward CG; Sörensen J; Porto L; Kieslich M; Klingebiel T; Bader P
    Eur J Pediatr; 2014 Oct; 173(10):1399-403. PubMed ID: 23881344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation.
    Torcoletti M; Petaccia A; Pinto RM; Hladnik U; Locatelli F; Agostoni C; Corona F
    Rheumatology (Oxford); 2014 Aug; 53(8):1533-4. PubMed ID: 24614645
    [No Abstract]   [Full Text] [Related]  

  • 16. Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content.
    Kyriakou K; Lederer CW; Kleanthous M; Drousiotou A; Malekkou A
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease.
    Cozma C; Iurașcu MI; Eichler S; Hovakimyan M; Brandau O; Zielke S; Böttcher T; Giese AK; Lukas J; Rolfs A
    Sci Rep; 2017 Jul; 7(1):6149. PubMed ID: 28733637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of ASAH1-related pure SMA evolving into adult-onset Farber disease.
    Puma A; Ezaru A; Cavalli M; Villa L; Torre F; Biancalana V; Levade T; Grecu N; Sacconi S
    Clin Genet; 2021 Aug; 100(2):234-235. PubMed ID: 34240417
    [No Abstract]   [Full Text] [Related]  

  • 19. Farber disease: report of three cases with joint involvement mimicking juvenile idiopathic arthritis.
    Moghadam SH; Tavasoli AR; Modaresi M; Ziaee V
    J Musculoskelet Neuronal Interact; 2019 Dec; 19(4):521-525. PubMed ID: 31789304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyarticular Arthritis and Spinal Muscular Atrophy in Acid Ceramidase Deficiency.
    Teoh HL; Solyom A; Schuchman EH; Mowat D; Roscioli T; Farrar M; Sampaio H
    Pediatrics; 2016 Oct; 138(4):. PubMed ID: 27650050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.